SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
50 hedge funds and large institutions have $52.2M invested in Sigilon Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
52% less capital invested
Capital invested by funds: $109M → $52.2M (-$56.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
50
Holding in Top 10
–
Calls
$84K
Puts
$48K
Top Buyers
| 1 | +$552K | |
| 2 | +$394K | |
| 3 | +$378K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$349K |
| 5 |
Renaissance Technologies
New York
|
+$247K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$1.79M | |
| 3 | -$1.3M | |
| 4 |
Millennium Management
New York
|
-$319K |
| 5 |
Morgan Stanley
New York
|
-$304K |